Fox Chase Adds Gastroenterologist with Cancer-Prevention Interests
PHILADELPHIA (Oct. 4, 2001)-David S. Weinberg, M.D., M.Sc., of Wynnewood, Pa., has joined the medical oncology staff at Fox Chase Cancer Center as director of gastroenterology. He holds a dual appointment as a member of the medical science and population science divisions.
Dr. Weinberg has a special interest in cancer prevention. He will have a key role in the Center's Gastrointestinal Tumor Risk Assessment Program.
"My goal is to enhance existing programs that look at people with very high risk or substantially elevated risk of gastrointestinal cancers," he said. "In addition, there are a variety of other things that I'm interested in, such as new chemoprevention studies, new ways to assess risk using molecular diagnostics, new ways to do colorectal cancer screening and new ways to prevent polyps."
He will also work with medical and surgical oncologists to follow patients after diagnosis and treatment to predict the risk of recurrence and help people reduce that risk.
Since 1995, Weinberg had served on the medical faculty of Thomas Jefferson University in Philadelphia. He was director of clinical research for Jefferson Medical College's division of gastroenterology and most recently was an associate professor of medicine.
He had also served as an adjunct assistant member of Fox Chase's division of population science, collaborating with senior scientist W. Thomas London, M.D. They are co-authors of a paper on pancreatic cancer published in July in Cancer Epidemiology, Biomarkers and Prevention.
Weinberg received his M.D. in 1989 from Cornell University Medical College, where he earned the Research Thesis Award and was a member of the Alpha Omega Alpha honorary society. He served his internship and residency in internal medicine at Beth Israel Hospital in Boston.
He then held a fellowship in gastroenterology at the University of Pennsylvania from 1992 to 1995. He was also a National Research Service Award fellow in cancer epidemiology from 1993 to 1995. After joining the staff of Jefferson, Weinberg earned an M.Sc. at the University of Pennsylvania in 1997.
Weinberg is a member of the American Gastroenterological Association's Committee on GI Research, the World Health Organization's Coordinating Committee for Colon Cancer and the National Institutes of Health Study Section - Clinical Oncology Emphasis Panel. He also serves on the editorial board of Evidence-Based Gastroenterology and is a guest editor for the bimonthly series "Molecular Medicine for Clinicians" in the Annals of Internal Medicine.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.